The roles of macrophage autophagy in atherosclerosis

Acta Pharmacologica Sinica

Volumn 37, Issue 2, 2016, Pages 150-156

  Shao, Bo Zong ^a   Han, Bin Ze ^a   Zeng, Yan Xia ^b   Su, Ding Feng ^a   Liu, Chong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Ji nan Military District of PLA ^*  (China)

Author keywords

atherosclerosis; autophagy; cholesterol efflux; macrophages

Indexed keywords

BECLIN 1; CALCIUM; CHOLESTEROL; EVEROLIMUS; FAT DROPLET; INFLAMMASOME; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RESVERATROL;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CALCIUM TRANSPORT; CHOLESTEROL TRANSPORT; DISEASE ASSOCIATION; DRUG TARGETING; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HUMAN; INFLAMMATION; MACROAUTOPHAGY; MACROPHAGE; MONOCYTE; NECROSIS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; ANIMAL; COMPLICATION; DRUG DEVELOPMENT; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY;

ANIMALS; ATHEROSCLEROSIS; AUTOPHAGY; CHOLESTEROL; DRUG DISCOVERY; HUMANS; INFLAMMATION; MACROPHAGES; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION;

EID: 84957558672     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2015.87     Document Type: Review

References (69)

1. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 2012; 15: 545-53.
2. Qian YN, Luo YT, Duan HX, Feng LQ, Bi Q, Wang YJ, et al. Adhesion molecule CD146 and its soluble form correlate well with carotid atherosclerosis and plaque instability. CNS Neurosci Ther 2014; 20: 438-45.
3. Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S, et al. Autophagy links inflammasomes to atherosclerotic progression. Cell Metab 2012; 15: 534-44.
4. Xu WH, Li ML, Niu JW, Feng F, Jin ZY, Gao S. Intracranial artery atherosclerosis and lumen dilation in cerebral small-vessel diseases: a high-resolution MRI Study. CNS Neurosci Ther 2014; 20: 364-7.
5. Chen SG, Xiao J, Liu XH, Liu MM, Mo ZC, Yin K, et al. Ibrolipim increases ABCA1/G1 expression by the LXR? signaling pathway in THP-1 macrophage-derived foam cells. Acta Pharmacol Sin 2010; 10: 1343-9.
6. Farese RV Jr, Walther TC. Lipid droplets finally get a little R-E-S-P-EC-T. Cell 2009; 139: 855-60.
7. Apostolakis S, Spandidos D. Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway. Acta Pharmacol Sin 2013; 34: 1251-6.
8. Hume DA. The mononuclear phagocyte system. Curr Opin Immunol 2006; 18: 49-53.
9. Liu YR, Chen JJ, Dai M. Paeonol protects rat vascular endothelial cells from ox-LDL-induced injury in vitro via downregulating microRNA-21 expression and TNF-? release. Acta Pharmacol Sin 2014; 35: 483-8.
10. Li Y, Liao F, Yin XJ, Cui LL, Ma GD, Nong XX, et al. An association study on ADAM10 promoter polymorphisms and atherosclerotic cerebral infarction in a Chinese population. CNS Neurosci Ther 2013; 19: 785-94.
11. Brown JD, Lin CY, Duan Q, Griffin G, Federation AJ, Paranal RM, et al. NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell 2014; 56: 219-31.
12. Shi RY, Zhu SH, Li V, Gibson SB, Xu XS, Kong JM. BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke. CNS Neurosci Ther 2014; 20: 1045-55.
13. Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010; 22: 124-31.
14. Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 2008; 9: 1004-10.
15. Qi H, Su FY, Wan S, Chen Y, Cheng YQ, Liu AJ. The antiaging activity and cerebral protection of rapamycin at micro-doses. CNS Neurosci Ther 2014; 20: 991-8.
16. He PX, Che YS, He QJ, Chen Y, Ding J. G226, a novel epipolythiodioxopiperazine derivative, induces autophagy and caspasedependent apoptosis in human breast cancer cells in vitro. Acta Pharmacol Sin 2014; 35: 1055-64.
17. Mizumura K, Choi AM, Ryter SW. Emerging role of selective autophagy in human diseases. Front Pharmacol 2014; 5: 244.
18. Shao BZ, Wei W, Ke P, Xu ZQ, Zhou JX, Liu C. Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome. CNS Neurosci Ther 2014; 20: 1021-8.
19. Wei N, Yu SP, Gu XH, Chen DD, Whalin MK, Xu GL, et al. The involvement of autophagy pathway in exaggerated ischemic brain damage in diabetic mice. CNS Neurosci Ther 2013; 19: 753-63.
20. Salabei JK, Conklin DJ. Cardiovascular autophagy: crossroads of pathology, pharmacology and toxicology. Cardiovasc Toxicol 2013; 13: 220-9.
21. Ryter SW, Lee SJ, Smith A, Choi AM. Autophagy in vascular disease. Proc Am Thorac Soc 2010; 7: 40-7.
22. Cardenas C, Miller RA, Smith I, Bui T, Molgo J, Muller M, et al. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 2010; 142: 270-83.
23. Decuypere JP, Kindt D, Luyten T, Welkenhuyzen K, Missiaen L, De Smedt H, et al. mTOR-controlled autophagy requires intracellular Ca2+ signaling. PloS One 2013; 8: e61020.
24. Kiffin R, Bandyopadhyay U, Cuervo AM. Oxidative stress and autophagy. Antioxid Redox Signal 2006; 8: 152-62.
25. Martinet W, Schrijvers DM, Timmermans JP, Bult H. Interactions between cell death induced by statins and 7-ketocholesterol in rabbit aorta smooth muscle cells. Br J Pharmacol 2008; 154: 1236-46.
26. Schrij vers DM, De Meyer GR, Mart inet W. Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler Thromb Vasc Biol 2011; 31: 2787-91.
27. Ling MY, Ma ZY, Wang YY, Qi J, Liu L, Li L, et al. Up-regulated ATPsensitive potassium channels play a role in increased inflammation and plaque vulnerability in macrophages. Atherosclerosis 2013; 226: 348-55.
28. Zhai C, Cheng J, Mujahid H, Wang H, Kong J, Yin Y, et al. Selective inhibition of PI3K/Akt/mTOR signaling pathway regulates autophagy of macrophage and vulnerability of atherosclerotic plaque. PloS One 2014; 9: e90563.
29. Li R, Ji Z, Qin H, Kang X, Sun B, Wang M, et al. Interference in autophagosome fusion by rare earth nanoparticles disrupts autophagic flux and regulation of an interleukin-1beta producing inflammasome. ACS Nano 2014; 8: 10280-92.
30. Khera AV, Rader DJ. Future therapeutic directions in reverse cholesterol transport. Curr Atheroscler Rep 2010; 12: 73-81.
31. Larkin JC, Sears SB, Sadovsky Y. The influence of ligand-activated LXR on primary human trophoblasts. Placenta 2014; 35: 919-24.
32. Yu X H , Fu YC , Z h a n g D W, Y i n K , Ta n g C K . Fo a m c e l l s i n atherosclerosis. Clin Chim Acta 2013; 424: 245-52.
33. Fu Y, Mukhamedova N, Ip S, D'Souza W, Henley KJ, DiTommaso T, et al. ABCA12 regulates ABCA1-dependent cholesterol efflux from macrophages and the development of atherosclerosis. Cell Metab 2013; 18: 225-38.
34. Ouimet M, Marcel YL. Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol 2012; 32: 575-81.
35. Narabayashi K, Ito Y, Eid N, Maemura K, Inoue T, Takeuchi T, et al. Indomethacin suppresses LAMP-2 expression and induces lipophagy and lipoapoptosis in rat enterocytes via the ER stress pathway. Int J Cell Biol 2015; 50: 541-54.
36. Singh R, Cuervo AM. Lipophagy: connecting autophagy and lipid metabolism. Int J Cell Biol 2012; 2012: 282041.
37. Liu K, Czaja MJ. Regulation of lipid stores and metabolism by lipophagy. Cell Death Differ 2013; 20: 3-11.
38. Ouimet M, Franklin V, Mak E, Liao X, Tabas I, Marcel YL. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab 2011; 13: 655-67.
39. Le Guezennec X, Brichkina A, Huang YF, Kostromina E, Han W, Bulavin DV. Wip1-dependent regulation of autophagy, obesity, and atherosclerosis. Cell Metab 2012; 16: 68-80.
40. Martin LA, Andre F, Campone M, Bachelot T, Jerusalem G. mTOR inhibitors in advanced breast cancer: ready for prime time? Cancer Treat Rev 2013; 39: 742-52.
41. Pal SK, Quinn DI. Differentiating mTOR inhibitors in renal cell carcinoma. Cancer Treat Rev 2013; 39: 709-19.
42. Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL, et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 2007; 3: 331-8.
43. Watanabe T, Kotani J, Murata Y, Seguchi O, Yanase M, Nakatani T. Tissue characterization of progressive cardiac allograft vasculopathy in patients with everolimus therapy compared with donor-transmitted atherosclerosis assessed using serial intravascular imaging: a case report. Transplant Proc 2014; 46: 2456-61.
44. Holdaas H, Potena L, Saliba F. mTOR inhibitors and dyslipidemia in transplant recipients: a cause for concern? Transplant Rev 2015; 29: 93-102.
45. Rosing K, Fobker M, Kannenberg F, Gunia S, Dell'Aquila AM, Kwiecien R, et al. Everolimus therapy is associated with reduced lipoproteinassociated phospholipase A(2) (Lp-Pla(2)) activity and oxidative stress in heart transplant recipients. Atherosclerosis 2013; 230: 164-70.
46. Hsu S, Koren E, Chan Y, Koscec M, Sheehy A, Kolodgie F, et al. Effects of everolimus on macrophage-derived foam cell behavior. Cardiovasc Revasc Med 2014; 15: 269-77.
47. Hoymans VY, VAN Dyck CJ, Haine SE, Frederix G, Fransen E, Timmermans JP, et al. Long-term vascular responses to Resolute(R) and Xience V(R) polymer-based drug-eluting stents in a rabbit model of atherosclerosis. J Interv Cardiol 2014; 27: 381-90.
48. Das M, Das DK. Resveratrol and cardiovascular health. Mol Aspects Med 2010; 31: 503-12.
49. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444: 337-42.
50. Calabriso N, Scoditti E, Massaro M, Pellegrino M, Storelli C, Ingrosso I, et al. Multiple anti-inflammatory and anti-atherosclerotic properties of red wine polyphenolic extracts: differential role of hydroxycinnamic acids, flavonols and stilbenes on endothelial inflammatory gene expression. Eur J Nutr 2015. Doi: 10.1007/s00394-015-0865-6.
51. Ginter E, Simko V, Panakova V. Antioxidants in health and disease. Bratisl Lek Listy 2014; 115: 603-6.
52. Cobb CA, Cole MP. Oxidative and nitrative stress in neurodegeneration. Neurobiol Dis 2015; 84: 4-21.
53. Kitada M, Koya D. Renal protective effects of resveratrol. Oxid Med Cell Longev 2013; 2013: 568093.
54. Liu B, Zhang B, Guo R, Li S, Xu Y. Enhancement in efferocytosis of oxidized low-density lipoprotein-induced apoptotic RAW264.7 cells through Sirt1-mediated autophagy. Int J Mol Med 2014; 33: 523-33.
55. Buttari B, Profumo E, Segoni L, D'Arcangelo D, Rossi S, Facchiano F, et al. Resveratrol counteracts inflammation in human M1 and M2 macrophages upon challenge with 7-oxo-cholesterol: potential therapeutic implications in atherosclerosis. Oxid Med Cell Longev 2014; 2014: 257543.
56. Wang Z, Zou J, Cao K, Hsieh TC, Huang Y, Wu JM. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med 2005; 16: 533-40.
57. Malhotra A, Bath S, Elbarbry F. An organ system approach to explore the antioxidative, anti-inflammatory, and cytoprotective actions of resveratrol. Oxid Med Cell Longev 2015; 2015: 803971.
58. Berbee JF, Wong MC, Wang Y, van der Hoorn JW, Khedoe PP, van Klinken JB, et al. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE 3-Leiden.CETP mice. J Nutr Biochem 2013; 24: 1423-30.
59. Fan X, Wang J, Hou J, Lin C, Bensoussan A, Chang D, et al. Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway. J Transl Med 2015; 13: 92.
60. Derosa G, Maffioli P, Cicero AF. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther 2012; 12: 1113-24.
61. Tillhon M, Guamán Ortiz LM, Lombardi P, Scovassi AI. Berberine: new perspectives for old remedies. Biochem Pharmacol 2012; 84: 1260-7.
62. Wang P, Xu TY, Wei K, Guan YF, Wang X, Xu H, et al. ARRB1/betaarrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia. Autophagy 2014; 10: 1535-48.
63. Zhang L, Dai F, Sheng PL, Chen ZQ, Xu QP, Guo YQ. Resveratrol analogue 3,4,4'-trihydroxy-trans-stilbene induces apoptosis and autophagy in human non-small-cell lung cancer cells in vitro. Acta Pharmacol Sin 2015; 36: 1256-65.
64. Shenoy SK, Lefkowitz RJ. Beta-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci 2011; 32: 521-33.
65. Kim J, Zhang L, Peppel K, Wu JH, Zidar DA, Brian L, et al. ?-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration. Circ Res 2008; 103: 70-9.
66. Jiang LS, Pu J, Han ZH, Hu LH, He B. Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages. Cardiovasc Res 2009; 81: 805-13.
67. Delsing DJ, Leijten FP, Arts K, van Eenennaam H, Garritsen A, Gijbels MJ, et al. Cannabinoid receptor 2 deficiency in Haematopoietic cells aggravates early atherosclerosis in LDL receptor deficient mice. Open Cardiovasc Med J 2011; 5: 15-21.
68. Steffens S, Mach F. Cannabinoid receptors in atherosclerosis. Curr Opin Lipidol 2006; 17: 519-26.
69. De Meyer I, Martinet W, De Meyer GR. Therapeutic strategies to deplete macrophages in atherosclerotic plaques. Br J Clin Pharmacol 2012; 74: 246-63.